NYSE · Medical - Diagnostics & Research

Agilent Technologies, Inc. (A) Stock

$173.07 -0.47% NYSE: A Healthcare

Valuation

MetricValue
Price$173.07
Market Cap$48.80B
P/E Ratio33.95
P/B Ratio6.62
P/S Ratio6.62
EPS (TTM)$4.57
52-Week High$178.07
52-Week Low$108.35
Dividend Yield0.59%

Financials & Margins

MetricValue
ROE20.47%
ROA10.31%
ROCE14.03%
Gross Margin21.29%
Operating Margin21.29%
Net Margin19.53%
Debt/Equity0.54
Current Ratio1.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.3B$6.8B$6.8B$6.5B$6.9B
Operating Profit$1.3B$1.6B$1.4B$1.5B$1.5B
Net Profit$1.2B$1.3B$1.2B$1.3B$1.3B
EPS$3.94$4.18$4.19$4.43$4.57
Op Margin21.3%23.6%19.8%22.9%21.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.7B$10.5B$10.8B$11.8B$12.7B
Total Liabilities$5.3B$5.2B$4.9B$5.9B$6.0B
Cash$1.5B$1.1B$1.6B$1.3B$1.8B
Borrowings$2.7B$2.8B$2.7B$3.6B$3.4B

Latest News

Agilent Strengthens Biopharma Growth Prospects With AI Expansion Zacks · Jul 9, 2026 Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize? Insider Monkey · Jul 8, 2026 Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis Business Wire · Jul 8, 2026 Agilent (A) Stock Looks Below Fair Value On Cash Flow Simply Wall St. · Jul 7, 2026 Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices PR Newswire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.5B$1.3B$1.8B$1.8B$1.6B
Investing Cash Flow$-938.0M$-629.0M$-608.0M$-1.6B$-801.0M
Financing Cash Flow$-816.0M$-1.1B$-630.0M$-1.1B$-464.0M
Net Cash Flow$43.0M$-434.0M$537.0M$-261.0M$459.0M
Free Cash Flow$1.3B$1.0B$1.5B$1.4B$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio1.79
EV / EBITDA25.90
FCF Yield2.94%
Quick Ratio1.56
Interest Coverage15.46
Return 1Y17.16%
Return 3Y65.99%
Return 5Y11.73%

Ownership

Insiders Held0.19%
Institutions Held94.06%
Institutions Float Held94.24%
Institutional HolderSharesReport Date
Blackrock Inc.25,902,6622026-03-31
Vanguard Capital Management LLC18,381,0302026-03-31
Vanguard Portfolio Management LLC14,352,6822026-03-31
State Street Corporation12,764,6322026-03-31
Massachusetts Financial Services Co.12,624,0902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOBio-Rad Laboratories, Inc. $369.95 +1.77% 44.31 $9.89B 0.00%
BRKRBruker Corporation $57.59 +0.49% -91.36 $8.77B 0.31%
DHRDanaher Corporation $230.50 +0.33% 39.76 $162.04B 0.71%
MTDMettler-Toledo International, Inc. $1670.29 -0.85% 36.42 $33.47B 0.00%
QGENQiagen N.V. $50.39 +0.34% 22.95 $10.38B 1.56%

About Agilent Technologies, Inc.

Agilent Technologies, Inc. is led by CEO Padraig McDonnell, employs 17,900 people, headquartered in Santa Clara, US, publicly traded since 1999.

Agilent Technologies, Inc. (A) stock trades at $173.07 with a market capitalization of $48.80B. The stock is valued at a price-to-earnings (P/E) ratio of 33.95, price-to-book of 6.62, price-to-sales of 6.62. Over the past 52 weeks the stock has ranged between $108.35 and $178.07, and currently trades 2.8% below its 52-week high. It pays a dividend yielding 0.59%.

On profitability, Agilent Technologies, Inc. generates a return on equity (ROE) of 20.47%, above the typical market range of roughly 12-15%, return on capital employed of 14.03%, an operating margin of 21.29%, a net profit margin of 19.53%.

In its most recent fiscal year, Agilent Technologies, Inc. reported annual revenue of $6.9B, net profit of $1.3B. Over the last 5 fiscal years, revenue grew at an average annual rate of 5.4%, and net profit grew at an average annual rate of 12.6%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.54, a current ratio of 1.96, total assets of $12.7B, $1.8B in cash and equivalents.

A has an average daily trading volume of 2,268,142 shares, a beta of 1.24.

Agilent Technologies, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Agilent Technologies, Inc. reported revenue of $4.2B rising to $6.9B, a change of +65.3% across 10 years. Compounded, revenue has grown 5.4% a year over five years, 0.5% over three, 6.7% over the last twelve months. Net profit rose to $1.3B.

Operating margin went from 14.6% in 2016 to 21.3% in 2025, a gain of 6.6 percentage points. The most recent net margin is 19.53%. On a trailing twelve-month basis to Jun '26, revenue is $7.4B and net profit $1.4B.

Borrowings rose from $1.9B to $3.4B, cash from operations was $1.6B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 21.7% over five years, and was 19.3% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Agilent Technologies, Inc. (A) — frequently asked questions

What is Agilent Technologies, Inc. (A) stock price today?

Agilent Technologies, Inc. (A) is currently trading at $173.07, down 0.47% today.

What is A P/E ratio?

Agilent Technologies, Inc.'s P/E ratio is 33.95. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is A return on equity (ROE)?

Agilent Technologies, Inc.'s return on equity (ROE) is 20.47%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is Agilent Technologies, Inc.'s market cap?

Agilent Technologies, Inc. has a market capitalization of $48.80B.

Does A pay a dividend?

Yes. Agilent Technologies, Inc. currently yields 0.59%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does A carry?

Agilent Technologies, Inc. has a debt-to-equity ratio of 0.54. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is A's profit margin?

Agilent Technologies, Inc. reports a net profit margin of 19.53% — the share of revenue left after every cost, including tax and interest.

What sector is A in?

Agilent Technologies, Inc. is classified under Healthcare, in the Medical - Diagnostics & Research industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is A listed on?

Agilent Technologies, Inc. trades on NYSE under the ticker A.

What is A's 52-week range?

Over the last year Agilent Technologies, Inc. has traded between $108.35 and $178.07.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens A currently matches

On the figures above, Agilent Technologies, Inc. passes the filters for 7 of our ready-made screens, among them High ROE Stocks, High ROA Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

High ROE StocksHigh ROA StocksLarge Cap StocksHealthcare Stocks To BuyLarge Cap Dividend StocksNYSE Listed StocksDebt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.